Aurobindo said Monday that its rivastigmine tartrate product 1. Rivastigmine tartrate capsules are indicated for the. On July 15, Global Pharmaceuticals received final FDA approval and commenced ...

A transdermal patch formulation of Novartis’ Alzheimer’s disease drug Exelon seems to offer the same efficacy as the current capsule formulation of the drug, and could make it easier for doctors to ...

Mar. 23 -- MONDAY, July 9 (HealthDay News) -- The Exelon skin patch (rivastigmine transdermal system) has been approved by the U.S. Food and Drug Administration to treat dementia associated with ...

Co announces Exelon Patch has received its first worldwide approval in the U.S. as a way to deliver an effective medicine for mild to moderate Alzheimer's disease patients through a skin patch instead ...